Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO

Archives of Gynecology and Obstetrics

Volumn 292, Issue 1, 2015, Pages 231-234

  Pölcher, Martin ^a   Hauptmann, Steffen ^b   Fotopoulou, Christina ^c   Schmalfeldt, Barbara ^d   Meinhold Heerlein, Ivo ^e   Mustea, Alexander ^f   Runnebaum, Ingo ^g   Sehouli, Jalid ^h  

^a Frauenklinik Rotkreuzklinikum   (Germany)

^b Krankenhaus Duren gem GmbH   (Germany)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^f UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^g JENA UNIVERSITY HOSPITAL   (Germany)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

BRCA; Cancer prevention; Hysterectomy; Opportunistic salpingectomy; Prophylactic salpingectomy; Serous high grade ovarian cancer; Serous tubal intra epithelial carcinoma

Indexed keywords

ADULT; CARCINOMA IN SITU; CYSTADENOCARCINOMA, SEROUS; EPITHELIUM; FALLOPIAN TUBE NEOPLASMS; FEMALE; HUMAN; MIDDLE AGED; MUTATION; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARIECTOMY; PATHOLOGY; PROCEDURES; SALPINGECTOMY; UTERINE TUBE;

ADULT; CARCINOMA IN SITU; CYSTADENOCARCINOMA, SEROUS; EPITHELIUM; FALLOPIAN TUBE NEOPLASMS; FALLOPIAN TUBES; FEMALE; HUMANS; MIDDLE AGED; MUTATION; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARIECTOMY; SALPINGECTOMY;

EID: 84937762869     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-015-3697-y     Document Type: Article

References (33)

1. Fathalla MF (1971) Incessant ovulation—a factor in ovarian neoplasia? Lancet 2(7716):163
2. Cramer DW, Welch WR (1983) Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 71(4):717–721
3. Bell DA, Scully RE (1994) Early de novo ovarian carcinoma. A study of fourteen cases. Cancer 73(7):1859–1864
4. Shih Ie M, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164(5):1511–1518
5. Crum CP et al (2007) The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol 19(1):3–9
6. Piek JM et al (2001) Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 195(4):451–456
7. Medeiros F et al (2006) The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 30(2):230–236
8. Kindelberger DW et al (2007) Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 31(2):161–169
9. Folkins AK et al (2009) Precursors to pelvic serous carcinoma and their clinical implications. Gynecol Oncol 113(3):391–396
10. Powell CB et al (2011) Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol. Int J Gynecol Cancer 21(5):846–851
11. Chivukula M et al (2011) Carcinomas of distal fallopian tube and their association with tubal intraepithelial carcinoma: do they share a common “precursor” lesion? loss of heterozygosity and immunohistochemical analysis using PAX 2, WT-1, and P53 markers. ISRN Obstet Gynecol 2011:858647
12. Paik DY et al (2012) Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation. Stem Cells 30(11):2487–2497
13. Tang S et al (2012) Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases. Int J Gynecol Pathol 31(2):103–110
14. Bijron JG et al (2013) Fallopian tube intraluminal tumor spread from noninvasive precursor lesions: a novel metastatic route in early pelvic carcinogenesis. Am J Surg Pathol 37(8):1123–1130
15. Gao FF et al (2013) Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin? Hum Pathol 44(8):1534–1543
16. Lee S et al (2013) Precursor lesions and prognostic factors in primary peritoneal serous carcinoma. Int J Gynecol Pathol 32(6):547–555
17. Reitsma W et al (2013) Support of the ‘fallopian tube hypothesis’ in a prospective series of risk-reducing salpingo-oophorectomy specimens. Eur J Cancer 49(1):132–141
18. Callahan MJ et al (2007) Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol 25(25):3985–3990
19. Przybycin CG et al (2010) Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol 34(10):1407–1416
20. Jacoby VL et al (2011) Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women’s Health Initiative Observational Study. Arch Intern Med 171(8):760–768
21. Parker WH et al (2013) Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses’ health study. Obstet Gynecol 121(4):709–716
22. Rocca WA et al (2006) Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 7(10):821–828
23. Repasy I et al (2009) Effect of the removal of the fallopian tube during hysterectomy on ovarian survival: the orphan ovary syndrome. Eur J Obstet Gynecol Reprod Biol 144(1):64–67
24. Sezik M et al (2007) Total salpingectomy during abdominal hysterectomy: effects on ovarian reserve and ovarian stromal blood flow. J Obstet Gynaecol Res 33(6):863–869
25. Petri Nahas EA (2005) Effect of total abdominal hysterectomy on ovarian blood supply in women of reproductive age. J Ultrasound Med 24(2):169–174
26. Findley AD et al (2013) Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial. Fertil Steril 100(6):1704–1708
27. Dar P et al (2000) Ovarian function before and after salpingectomy in artificial reproductive technology patients. Hum Reprod 15(1):142–144
28. Vorwergk J et al (2014) Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate. J Cancer Res Clin Oncol 140(5):859–865
29. Guldberg R et al (2013) Salpingectomy as standard at hysterectomy? A Danish cohort study, 1977–2010. BMJ Open 3(6). doi:10.1136/bmjopen-2013-002845
30. Kauff ND et al (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346(21):1609–1615
31. Foulkes WD (2013) Preventing ovarian cancer by salpingectomy. Curr Oncol 20(3):139–142
32. Miller DM et al (2013) Opportunistic salpingectomy: the way forward-response to Steven Narod. Curr Oncol 20(3):143–144
33. Muller A et al (2010) Hysterectomy-a comparison of approaches. Dtsch Arztebl Int 107(20):353–359